📣 Join the 4th Annual EANO/SNO Highlights Webinar
Top abstracts from #EANO2025 (Prague) & #SNO2025 (Honolulu) – latest advances in neuro-oncology.
🗓 Feb 6, 2026 | ⏰ 18:30–19:30 CET
🎟 Free for #EANO & #SNO members
👉 Register now: bit.ly/EANO-SNO-2025
#NeuroOncology @neuroonc.bsky.social
Top abstracts from #EANO2025 (Prague) & #SNO2025 (Honolulu) – latest advances in neuro-oncology.
🗓 Feb 6, 2026 | ⏰ 18:30–19:30 CET
🎟 Free for #EANO & #SNO members
👉 Register now: bit.ly/EANO-SNO-2025
#NeuroOncology @neuroonc.bsky.social
January 19, 2026 at 3:41 PM
📣 Join the 4th Annual EANO/SNO Highlights Webinar
Top abstracts from #EANO2025 (Prague) & #SNO2025 (Honolulu) – latest advances in neuro-oncology.
🗓 Feb 6, 2026 | ⏰ 18:30–19:30 CET
🎟 Free for #EANO & #SNO members
👉 Register now: bit.ly/EANO-SNO-2025
#NeuroOncology @neuroonc.bsky.social
Top abstracts from #EANO2025 (Prague) & #SNO2025 (Honolulu) – latest advances in neuro-oncology.
🗓 Feb 6, 2026 | ⏰ 18:30–19:30 CET
🎟 Free for #EANO & #SNO members
👉 Register now: bit.ly/EANO-SNO-2025
#NeuroOncology @neuroonc.bsky.social
Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies
Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies
News update via NF Bot
pubmed.ncbi.nlm.nih.gov
January 13, 2026 at 3:41 PM
Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies
Knickerbocker is an Air Force veteran and works as a neuro-oncology nurse practitioner at the Ohio State University Wexner Medical Center. She has also worked for the 88th Air Base Wing at Wright-Patterson, according to her campaign announcement. daytondailynews.com/local/air-fo...
Air Force veteran, Democrat joins race to challenge Turner for congressional seat
Air Force veteran to take on Turner for congressional seat
daytondailynews.com
January 13, 2026 at 12:39 PM
Knickerbocker is an Air Force veteran and works as a neuro-oncology nurse practitioner at the Ohio State University Wexner Medical Center. She has also worked for the 88th Air Base Wing at Wright-Patterson, according to her campaign announcement. daytondailynews.com/local/air-fo...
Neuro-oncology — Dec 2025 🧠🧬
Brain mets, gliomas & immunotherapy moved fast last month:
• Liquid biopsy hits 98% accuracy from blood
• CNS tumor classes expand to 184 types
• New immune strategies boost antitumor response
Full summary: pir.sh/z0odQpM1LO
#NeuroOncology #Glioblastoma #LiquidBiopsy
Brain mets, gliomas & immunotherapy moved fast last month:
• Liquid biopsy hits 98% accuracy from blood
• CNS tumor classes expand to 184 types
• New immune strategies boost antitumor response
Full summary: pir.sh/z0odQpM1LO
#NeuroOncology #Glioblastoma #LiquidBiopsy
Summarized Science - Research on Neuro Oncology in December of 2025
Latest research highlights and monthly summaries for Neuro Oncology. AI-powered analysis of the latest scientific publications and research trends.
pir.sh
January 8, 2026 at 8:41 PM
Neuro-oncology — Dec 2025 🧠🧬
Brain mets, gliomas & immunotherapy moved fast last month:
• Liquid biopsy hits 98% accuracy from blood
• CNS tumor classes expand to 184 types
• New immune strategies boost antitumor response
Full summary: pir.sh/z0odQpM1LO
#NeuroOncology #Glioblastoma #LiquidBiopsy
Brain mets, gliomas & immunotherapy moved fast last month:
• Liquid biopsy hits 98% accuracy from blood
• CNS tumor classes expand to 184 types
• New immune strategies boost antitumor response
Full summary: pir.sh/z0odQpM1LO
#NeuroOncology #Glioblastoma #LiquidBiopsy
Pleased to announce that UMMH Cancer Center became our newest member in December 2025. Led by Dr. David Cachia, interim chief of Hematology Oncology Services and associate professor of neuro-oncology at the University of Massachusetts. Read more here: bit.ly/45EUIBw #AACIUpdate
January 7, 2026 at 7:52 PM
Pleased to announce that UMMH Cancer Center became our newest member in December 2025. Led by Dr. David Cachia, interim chief of Hematology Oncology Services and associate professor of neuro-oncology at the University of Massachusetts. Read more here: bit.ly/45EUIBw #AACIUpdate
Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies
Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies
News update via NF Bot
pubmed.ncbi.nlm.nih.gov
January 7, 2026 at 11:39 AM
Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies
To me, endemjc means "predictable," but i think this isn't true for COVID-19. There are cardiovascular docs and neuro-vascular surgeons who believe that C19, even mild cases, is involved in major vascular events, like TIAs, aneurysms, and strokes
There are oncology researchers who believe it's
There are oncology researchers who believe it's
January 7, 2026 at 6:27 AM
To me, endemjc means "predictable," but i think this isn't true for COVID-19. There are cardiovascular docs and neuro-vascular surgeons who believe that C19, even mild cases, is involved in major vascular events, like TIAs, aneurysms, and strokes
There are oncology researchers who believe it's
There are oncology researchers who believe it's
Timing matters: @erikherzog.bsky.social @washu.edu , Joshua Rubin and team analyzed 5 years of glioblastoma biopsy results and conclude, “We are hopeful that this chronodiagnostic approach will help identify better ways to treat this devastating disease.” Published in the Journal of Neuro-Oncology.
Timing may be key to effective cancer treatments
Researchers at Washington University in St. Louis find the timing of biopsy can affect how doctors diagnose tumors and when those cancers may be more sensitive to chemotherapy.
bit.ly
January 6, 2026 at 4:46 PM
Timing matters: @erikherzog.bsky.social @washu.edu , Joshua Rubin and team analyzed 5 years of glioblastoma biopsy results and conclude, “We are hopeful that this chronodiagnostic approach will help identify better ways to treat this devastating disease.” Published in the Journal of Neuro-Oncology.
"There is interest in harnessing endovascular neurointerventional techniques for diagnostics and therapeutics in neuro-oncology. We report the current state of practice and @SNISinfo's efforts to develop an organizational platform to treat patients and advance research in this emerging field."
January 5, 2026 at 4:00 PM
"There is interest in harnessing endovascular neurointerventional techniques for diagnostics and therapeutics in neuro-oncology. We report the current state of practice and @SNISinfo's efforts to develop an organizational platform to treat patients and advance research in this emerging field."
Our impact is so much greater when we partner with others. This year we:
🤝Co-promoted #MyTumorID with affiliate organizations
🤝Connected private industry with academic research through #BTIF
🤝Convened thought leaders to plan the future of neuro-oncology therapy development
🤝Co-promoted #MyTumorID with affiliate organizations
🤝Connected private industry with academic research through #BTIF
🤝Convened thought leaders to plan the future of neuro-oncology therapy development
December 31, 2025 at 9:56 PM
Our impact is so much greater when we partner with others. This year we:
🤝Co-promoted #MyTumorID with affiliate organizations
🤝Connected private industry with academic research through #BTIF
🤝Convened thought leaders to plan the future of neuro-oncology therapy development
🤝Co-promoted #MyTumorID with affiliate organizations
🤝Connected private industry with academic research through #BTIF
🤝Convened thought leaders to plan the future of neuro-oncology therapy development
2025 was a big year for us!
• Presented our Glioblastoma Disparities Survey at SNO & ASCO
• Close to launching our innovative DANO-GBM (Digital Assessment Neuro-Oncology for GBM) project with Harvard
Please consider a gift so we can reach our goal of $15,000 in 2025. Thank you! (link in comments)
• Presented our Glioblastoma Disparities Survey at SNO & ASCO
• Close to launching our innovative DANO-GBM (Digital Assessment Neuro-Oncology for GBM) project with Harvard
Please consider a gift so we can reach our goal of $15,000 in 2025. Thank you! (link in comments)
December 31, 2025 at 6:13 PM
2025 was a big year for us!
• Presented our Glioblastoma Disparities Survey at SNO & ASCO
• Close to launching our innovative DANO-GBM (Digital Assessment Neuro-Oncology for GBM) project with Harvard
Please consider a gift so we can reach our goal of $15,000 in 2025. Thank you! (link in comments)
• Presented our Glioblastoma Disparities Survey at SNO & ASCO
• Close to launching our innovative DANO-GBM (Digital Assessment Neuro-Oncology for GBM) project with Harvard
Please consider a gift so we can reach our goal of $15,000 in 2025. Thank you! (link in comments)
Researchers with @ohsunews.bsky.social's Neuro-Oncology Blood-Brain Barrier Program supported several clinical trials investigating a novel use of a drug for brain cancer imaging. https://news.ohsu.edu/2025/12/17/ohsu-research-drives-fda-approval-for-novel-use-of-anemia-drug-in-brain-cancer-imaging
OHSU research drives FDA approval for novel use of anemia drug in brain cancer imaging
OHSU lab started exploring new use of the drug 30 years ago; now, it may improve techniques to measure, monitor aggressive brain tumors.
news.ohsu.edu
December 22, 2025 at 8:50 PM
Researchers with @ohsunews.bsky.social's Neuro-Oncology Blood-Brain Barrier Program supported several clinical trials investigating a novel use of a drug for brain cancer imaging. https://news.ohsu.edu/2025/12/17/ohsu-research-drives-fda-approval-for-novel-use-of-anemia-drug-in-brain-cancer-imaging
🏥 Dana-Farber Cancer Institute's Neuro-Inclusive Oncology Care & Empowerment Program is rethinking #cancercare for patients with intellectual and developmental disabilities—prioritizing communication, sensory needs, and workforce training.
✍️ Melissa Levin, MSW, LICSW
🔗 https://ow.ly/yBzM50XNfIJ
✍️ Melissa Levin, MSW, LICSW
🔗 https://ow.ly/yBzM50XNfIJ
December 22, 2025 at 7:30 PM
🏥 Dana-Farber Cancer Institute's Neuro-Inclusive Oncology Care & Empowerment Program is rethinking #cancercare for patients with intellectual and developmental disabilities—prioritizing communication, sensory needs, and workforce training.
✍️ Melissa Levin, MSW, LICSW
🔗 https://ow.ly/yBzM50XNfIJ
✍️ Melissa Levin, MSW, LICSW
🔗 https://ow.ly/yBzM50XNfIJ
“The FDA approval of ferumoxytol for imaging is an exciting advancement for the field of neuro-oncology because it offers a new approach to imaging assessment, which may lead to improving the quality of life for patients.”
- Dr. Ramon Barajas on #OHSUResearch: https://bit.ly/4rW8YPY
- Dr. Ramon Barajas on #OHSUResearch: https://bit.ly/4rW8YPY
OHSU research drives FDA approval for novel use of anemia drug in brain cancer imaging
OHSU lab started exploring new use of the drug 30 years ago; now, it may improve techniques to measure, monitor aggressive brain tumors.
bit.ly
December 19, 2025 at 4:47 PM
“The FDA approval of ferumoxytol for imaging is an exciting advancement for the field of neuro-oncology because it offers a new approach to imaging assessment, which may lead to improving the quality of life for patients.”
- Dr. Ramon Barajas on #OHSUResearch: https://bit.ly/4rW8YPY
- Dr. Ramon Barajas on #OHSUResearch: https://bit.ly/4rW8YPY
At the The Society for Neuro-Oncology 30th anniversary annual meeting, NBTS president & CEO David Arons sat down with Dr. Rachna Malani to talk about how we’re working to advance effective treatments & advocating for patients and caregivers.
Watch now: https://www.youtube.com/watch?v=ldhzO03_Rxw
Watch now: https://www.youtube.com/watch?v=ldhzO03_Rxw
December 17, 2025 at 9:51 PM
At the The Society for Neuro-Oncology 30th anniversary annual meeting, NBTS president & CEO David Arons sat down with Dr. Rachna Malani to talk about how we’re working to advance effective treatments & advocating for patients and caregivers.
Watch now: https://www.youtube.com/watch?v=ldhzO03_Rxw
Watch now: https://www.youtube.com/watch?v=ldhzO03_Rxw
Latests talks and seminars from the #RENACER team, sharing new advances in neuro-oncology:
➡️ Manuel Valiente, gave a webinar within PETRAnetwork
➡️ Mª Jesús Artiga, presented RENACER at the 20th Ibero-American Congress of Cancer Patients (GEPAC)
➡️ Manuel Valiente, gave a webinar within PETRAnetwork
➡️ Mª Jesús Artiga, presented RENACER at the 20th Ibero-American Congress of Cancer Patients (GEPAC)
December 17, 2025 at 3:33 PM
Latests talks and seminars from the #RENACER team, sharing new advances in neuro-oncology:
➡️ Manuel Valiente, gave a webinar within PETRAnetwork
➡️ Mª Jesús Artiga, presented RENACER at the 20th Ibero-American Congress of Cancer Patients (GEPAC)
➡️ Manuel Valiente, gave a webinar within PETRAnetwork
➡️ Mª Jesús Artiga, presented RENACER at the 20th Ibero-American Congress of Cancer Patients (GEPAC)
## Automated Computational Pathology Pipeline for Early-Stage Glioma Diagnosis using Humanized Mouse Models and Integrated Multi-Omics Data
**Abstract:** Early and accurate diagnosis of glioma remains a critical challenge in neuro-oncology due to the heterogeneity and subtle initial presentations…
**Abstract:** Early and accurate diagnosis of glioma remains a critical challenge in neuro-oncology due to the heterogeneity and subtle initial presentations…
## Automated Computational Pathology Pipeline for Early-Stage Glioma Diagnosis using Humanized Mouse Models and Integrated Multi-Omics Data
**Abstract:** Early and accurate diagnosis of glioma remains a critical challenge in neuro-oncology due to the heterogeneity and subtle initial presentations of these tumors. This research proposes an automated computational pathology pipeline leveraging data generated from humanized mouse models of glioma and integrating multi-omics data (histopathology, gene expression, proteomics) to achieve enhanced diagnostic accuracy and accelerated drug development. The pipeline employs a novel Multi-layered Evaluation Pipeline (MLEP) architecture incorporating semantic decomposition, rigorous logical consistency checks, and advanced machine learning algorithms to identify early-stage glioma biomarkers and predict patient response to therapeutic interventions.
freederia.com
December 15, 2025 at 10:08 AM
## Automated Computational Pathology Pipeline for Early-Stage Glioma Diagnosis using Humanized Mouse Models and Integrated Multi-Omics Data
**Abstract:** Early and accurate diagnosis of glioma remains a critical challenge in neuro-oncology due to the heterogeneity and subtle initial presentations…
**Abstract:** Early and accurate diagnosis of glioma remains a critical challenge in neuro-oncology due to the heterogeneity and subtle initial presentations…
Melissa Levin, MSW, LICSW, recently talked with @ascopost.bsky.social about our Neuro-Inclusive Oncology Care and Empowerment Program. Learn more: bit.ly/4rPKRCJ
Eliminating Barriers to Care for Patients With Intellectual and/or Developmental Disabilities
A recent large, retrospective study by Giblon et al has found that individuals with intellectual and/or developmental disabilities face an increased risk of developing cancer, higher symptom burden on...
bit.ly
December 14, 2025 at 1:30 PM
Melissa Levin, MSW, LICSW, recently talked with @ascopost.bsky.social about our Neuro-Inclusive Oncology Care and Empowerment Program. Learn more: bit.ly/4rPKRCJ
Our Neuro-Inclusive Oncology Care and Empowerment Program provides specialized care for patients with intellectual and developmental disabilities & communication training for health care providers. @danafarber.bsky.social’s Melissa Levin, MSW, LICSW talks w/ @ascocancer.bsky.sociall: bit.ly/3YpHXa4
Eliminating Barriers to Care for Patients With Intellectual and/or Developmental Disabilities
A recent large, retrospective study by Giblon et al has found that individuals with intellectual and/or developmental disabilities face an increased risk of developing cancer, higher symptom burden on...
bit.ly
December 12, 2025 at 8:00 PM
Our Neuro-Inclusive Oncology Care and Empowerment Program provides specialized care for patients with intellectual and developmental disabilities & communication training for health care providers. @danafarber.bsky.social’s Melissa Levin, MSW, LICSW talks w/ @ascocancer.bsky.sociall: bit.ly/3YpHXa4
Amylin’s signaling mechanisms overlap with neuroendocrine pathways, interesting for:
neuro-oncology
peptide BBB penetration
glioma metabolic disruption
neuro-oncology
peptide BBB penetration
glioma metabolic disruption
December 12, 2025 at 4:46 AM
Amylin’s signaling mechanisms overlap with neuroendocrine pathways, interesting for:
neuro-oncology
peptide BBB penetration
glioma metabolic disruption
neuro-oncology
peptide BBB penetration
glioma metabolic disruption
Consequences of Acute Presentations of Functional Neurological Disorders in Neuro‐Oncology Patients: Case Series and Systematic Review Br&Beh
Consequences of Acute Presentations of Functional Neurological Disorders in Neuro‐Oncology Patients: Case Series and Systematic Review
Brain and Behavior, Volume 15, Issue 12, December 2025.
dlvr.it
December 11, 2025 at 6:42 PM
Consequences of Acute Presentations of Functional Neurological Disorders in Neuro‐Oncology Patients: Case Series and Systematic Review Br&Beh
🧠 Advances in neuro-oncology drive the Glioma Diagnosis & Treatment Market. Read more: www.marketresearchfuture.com/reports/glio... #NeuroOncology #CancerCare
Glioma Diagnosis and Treatment Market Size, Growth, By 2035
Glioma Diagnosis and Treatment Market market share register 3.58 Billion USD in 2024, projected to grow 5.20 % CAGR to reach USD 6.25 Billion during the forecast period 2025 - 2035.
www.marketresearchfuture.com
December 11, 2025 at 7:23 AM
🧠 Advances in neuro-oncology drive the Glioma Diagnosis & Treatment Market. Read more: www.marketresearchfuture.com/reports/glio... #NeuroOncology #CancerCare
Students and an alum will share fresh insights on immune responses in brain tumors at Friday's MD Anderson Brain Tumor Center–Cancer Neuroscience Seminar — featuring research they recently presented at the Society for Neuro-Oncology Meeting. Learn more at: https://loom.ly/NNOTrZo
December 10, 2025 at 9:13 PM
Students and an alum will share fresh insights on immune responses in brain tumors at Friday's MD Anderson Brain Tumor Center–Cancer Neuroscience Seminar — featuring research they recently presented at the Society for Neuro-Oncology Meeting. Learn more at: https://loom.ly/NNOTrZo
Towards excellence: a review of brain tumour care for children across the UK
Tessa Jowell Brain Cancer Mission This review of paediatric neuro-oncology services highlights both the excellence and inequities in care for children and young people with a brain tumour. Covering 15 centres,…
Tessa Jowell Brain Cancer Mission This review of paediatric neuro-oncology services highlights both the excellence and inequities in care for children and young people with a brain tumour. Covering 15 centres,…
Towards excellence: a review of brain tumour care for children across the UK
Tessa Jowell Brain Cancer Mission This review of paediatric neuro-oncology services highlights both the excellence and inequities in care for children and young people with a brain tumour. Covering 15 centres, representing 94% of the UK population, the review assessed 168 elements of the patient pathway, and draws on extensive centre data, clinical interviews and feedback from more than 200 families.
trfthealthweeklydigest.wordpress.com
December 9, 2025 at 8:38 AM
Towards excellence: a review of brain tumour care for children across the UK
Tessa Jowell Brain Cancer Mission This review of paediatric neuro-oncology services highlights both the excellence and inequities in care for children and young people with a brain tumour. Covering 15 centres,…
Tessa Jowell Brain Cancer Mission This review of paediatric neuro-oncology services highlights both the excellence and inequities in care for children and young people with a brain tumour. Covering 15 centres,…
So much exciting progress in the fight against #BrainTumors presented at this year's Society for Neuro-Oncology Annual Meeting #SNO2025. Thanks to all the incredible @neuroonc.bsky.social staff and colleagues around the world for putting this conference together! Looking forward to #SNO2026
December 7, 2025 at 10:51 PM
So much exciting progress in the fight against #BrainTumors presented at this year's Society for Neuro-Oncology Annual Meeting #SNO2025. Thanks to all the incredible @neuroonc.bsky.social staff and colleagues around the world for putting this conference together! Looking forward to #SNO2026